Coegin Pharma Future Growth
Future criteria checks 2/6
Coegin Pharma is forecast to grow earnings and revenue by 16.4% and 109.2% per annum respectively.
Key information
16.4%
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 109.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 24 | N/A | N/A | N/A | 1 |
| 12/31/2025 | 14 | -20 | -20 | -20 | 1 |
| 12/31/2024 | N/A | -22 | -22 | -22 | 1 |
| 6/30/2024 | N/A | -26 | -22 | -22 | N/A |
| 3/31/2024 | N/A | -28 | -21 | -21 | N/A |
| 12/31/2023 | N/A | -28 | -22 | -22 | N/A |
| 9/30/2023 | N/A | -28 | -23 | -23 | N/A |
| 6/30/2023 | N/A | -29 | -23 | -23 | N/A |
| 3/31/2023 | N/A | -35 | -33 | -33 | N/A |
| 12/31/2022 | N/A | -35 | -38 | -38 | N/A |
| 9/30/2022 | N/A | -36 | -37 | -37 | N/A |
| 3/31/2022 | N/A | -23 | -31 | -31 | N/A |
| 12/31/2021 | N/A | -27 | -21 | -21 | N/A |
| 9/30/2021 | -3 | -61 | -26 | -26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7Z6 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 7Z6 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 7Z6 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 7Z6's revenue (109.2% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 7Z6's revenue (109.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 7Z6's Return on Equity is forecast to be high in 3 years time